CHICAGO, July 24, 2017 -- Mattersight Corporation (NASDAQ:MATR), the pioneer in personality-based software applications, today announced that it intends to release its second quarter 2017 financial results after the market close on Tuesday, August 8, 2017. Mattersight management also plans to host a conference call at 5:00 p.m. Eastern Time on Tuesday, August 8, 2017.
The conference call and slide presentation will be available at the Investor Relations section of Mattersight's website at http://www.mattersight.com/about-us/investor-relations/. To listen to the conference call via telephone, please call 800.952.4789 (domestic) or 404.665.9579 (international), conference ID: 57891222.
For those who cannot access the live broadcast, a replay of the conference call will be available beginning approximately two hours after the live call is completed until September 8, 2017, by dialing 855.859.2056 (domestic) or 404.537.3406 (international), conference ID: 57891222.
About Mattersight
Mattersight's mission is to help brands have more effective and effortless conversations with their customers. Using a suite of innovative personality-based software applications, Mattersight can analyze and predict customer behavior based on the language exchanged during service and sales interactions. This insight can then facilitate real-time connections between customers and the agents best capable of handling their needs. Mattersight's stack of patented SaaS applications has influenced hundreds of millions of shorter, more satisfying customer interactions. Organizations across the Financial Services, Healthcare and Telco industries rely on Mattersight to drive customer retention, employee engagement and operating efficiency. An independent research study documents the average return on investment for these organizations is 344%. To learn more about how Mattersight can help your company, please visit www.mattersight.com.
Contact David Mullen Chief Financial Officer 312.954.7380 [email protected]


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Italy Fines Apple €98.6 Million Over App Store Dominance
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



